Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000337022 | SCV000337415 | uncertain significance | not provided | 2018-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001265687 | SCV001443854 | uncertain significance | Inborn genetic diseases | 2019-01-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001303665 | SCV001492916 | pathogenic | Bethlem myopathy 1A | 2023-09-26 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 733 of the COL6A2 protein (p.Gly733Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant COL6A2-related conditions (PMID: 30564623, 34167565). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 284693). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COL6A2 protein function. For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV000337022 | SCV001747335 | uncertain significance | not provided | 2021-06-01 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000337022 | SCV003832530 | uncertain significance | not provided | 2023-01-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000337022 | SCV005376416 | uncertain significance | not provided | 2024-04-17 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33441455, 30564623, 34167565) |
Division of Human Genetics, |
RCV000477924 | SCV000536776 | uncertain significance | Bethlem myopathy 1A; Ullrich congenital muscular dystrophy 1A; Myosclerosis | 2015-06-20 | no assertion criteria provided | research | |
Genome Diagnostics Laboratory, |
RCV000337022 | SCV001809096 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000337022 | SCV001956182 | uncertain significance | not provided | no assertion criteria provided | clinical testing |